Showing results (611-620 of 698) with videos related to

Sort By:
Pageof 70
Journal of the American Chemical Society|March 9, 2023
Largely Pseudocapacitive Two-Dimensional Conjugated Metal-Organic Framework Anodes with Lowest Unoccupied Molecular Orbital Localized in Nickel-bis(dithiolene) LinkagesPanpan Zhang, Mingchao Wang, Yannan Liu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 12, 2026
Posterior communicating artery variation is linked to compromised cerebral hemodynamics in middle-aged and older adultsFrancis E Cambronero, Panpan Zhang, W Hudson Robb, et al.
Cancer Immunology, Immunotherapy : CII|June 13, 2026
Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trialPanpan Zhang, Ming Lu, Lijie Song, et al.
Seminars in Arthritis and Rheumatism|May 11, 2023
The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from ChinaZheng Liu, Yuxue Nie, Yu Peng, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
The association between poor sleep health and Alzheimer's disease structural neuroimaging biomarkersEmma Nolan, Yunyi Sun, Hui Shi, et al.
Journal of Agricultural and Food Chemistry|August 18, 2021
PLGA-PEG Nanoparticles Facilitate In Vivo Anti-Alzheimer's Effects of Fucoxanthin, a Marine Carotenoid Derived from Edible Brown AlgaeMengxiang Yang, Lingli Jin, Zhuoying Wu, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trialYing Cheng, Panpan Zhang, Ming Lu, et al.
Asia-Pacific Journal of Clinical Oncology|January 29, 2026
Treatment Efficacy, Chemoradiotherapy Benefits, and Survival Disparities by Histology in Primary Mediastinal Germ Cell Tumors: 15-Year Results of a Single-Center Cohort StudyDi Wu, Ziran Zhang, Jun Nie, et al.
Arthritis Research & Therapy|April 8, 2021
Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort studyLinyi Peng, Hui Lu, Jiaxin Zhou, et al.
Rheumatology (Oxford, England)|November 19, 2020
Differences in clinical characteristics of IgG4-related disease across age groups: a prospective study of 737 patientsHui Lu, Fei Teng, Panpan Zhang, et al.
Pageof 70